Cronos (CRON) Restructuring Costs (2023 - 2026)

Cronos' (CRON) quarterly Restructuring Costs came in at $484000.0 in Q1 2026, down 12.79% year-on-year from $555000.0 in Q1 2025, and down 3.59% quarter-over-quarter from $502000.0 in Q4 2025.

Cronos (CRON) Restructuring Costs (2023 - 2026) Analysis & Trends

Cronos' Restructuring Costs history runs 4 years deep, the most recent figure standing at $484000.0 for Q1 2026.

  • On a quarterly basis, Restructuring Costs fell 12.79% year-over-year to $484000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 78.4% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 223.33% from the prior year.
  • Restructuring Costs fell to $484000.0 in Q1 2026 per CRON's latest filing, from $502000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $1.4 million in Q3 2023 and bottomed at $83000.0 in Q1 2024.
  • The 4-year median for Restructuring Costs is $502000.0 (2025), against an average of $519444.4.
  • Across the five-year window, Restructuring Costs soared 568.67% in 2025 and decreased 12.79% in 2026, its largest moves.
  • Year by year, Restructuring Costs stood at $101000.0 in 2023, then surged by 441.58% to $547000.0 in 2024, then declined by 8.23% to $502000.0 in 2025, then fell by 3.59% to $484000.0 in 2026.
  • Per Business Quant, the three latest CRON Restructuring Costs figures stand at $484000.0 (Q1 2026), $502000.0 (Q4 2025), and $212000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 484,000.00
Dec 31, 2025 502,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 768,000.00
Mar 31, 2025 555,000.00
Jun 30, 2024 547,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 1.42 Mn